AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31639022 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative feedback
Number of subjects: 85
Study 31639022 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly patients
Number of subjects: 85
Study 31639022 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 85
Study 31639022 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmarried individuals
Number of subjects: 85
Study 31639022 — intervention group
Group type: COMPARATOR
Intervention: Different levels of education
Number of subjects: 85
Study 28391880 — intervention group
Group type: EXPERIMENTAL
Intervention: Kefir drink
Number of subjects: 75
Study 28391880 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat milk
Number of subjects: 75
Study 28391880 — intervention group
Group type: COMPARATOR
Intervention: Control group (weight-maintenance diet with 2 servings/d of low-fat dairy products)
Number of subjects: 75
Study 27515877 — intervention group
Group type: EXPERIMENTAL
Intervention: Sage tea-thyme-peppermint hydrosol oral rinse
Number of subjects: 60
Study 27515877 — intervention group
Group type: COMPARATOR
Intervention: Basic oral care (Control)
Number of subjects: 60
Study 27515877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Intervention and Control)
Number of subjects: 60
Study 24958796 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal carriage of Staphylococcus aureus
Number of subjects: 928
Study 24958796 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand carriage of Staphylococcus aureus
Number of subjects: 928
Study 24958796 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA nasal carriers
Number of subjects: 928
Study 24958796 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand MRSA carriage without nasal S. aureus carriage
Number of subjects: 928
Study 24958796 — intervention group
Group type: COMPARATOR
Intervention: Duration of jail stay
Number of subjects: 928
Study 21153759 — intervention group
Group type: EXPERIMENTAL
Intervention: Just for You (JFY) Program
Number of subjects: 679
Study 21153759 — intervention group
Group type: COMPARATOR
Intervention: Usual WIC Care
Number of subjects: 679
Study 20408942 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction (4-h sleep for 5 days)
Number of subjects: 20
Study 20408942 — intervention group
Group type: COMPARATOR
Intervention: Control (8-h sleep each night)
Number of subjects: 20
Study 20408942 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery (8-h sleep for 2 days after SR)
Number of subjects: 20
Study 17903056 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemorrhoidectomy with sphincterotomy (Group A)
Number of subjects: 120
Study 17903056 — intervention group
Group type: COMPARATOR
Intervention: Hemorrhoidectomy alone (Group B)
Number of subjects: 120
Study 15722783 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids for chronic nonmalignant pain management
Number of subjects: 0
Study 15722783 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12236852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 0.25 mg, 1 mg, or 10 mg with Simvastatin 10 mg
Number of subjects: 82
Study 12236852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg with Simvastatin 10 mg or 20 mg
Number of subjects: 82
Study 12236852 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10 mg alone
Number of subjects: 82
Study 12236852 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg alone
Number of subjects: 82
Study 9929524 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin (200 mg orally, twice daily for six months)
Number of subjects: 140
Study 9929524 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily for six months)
Number of subjects: 140
Study 9929524 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin
Number of subjects: 140
Study 9929524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 7567754 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol/balanced electrolyte (PEG) mixture
Number of subjects: 89
Study 7567754 — intervention group
Group type: COMPARATOR
Intervention: Mannitol/Picolax mixture
Number of subjects: 89
Study 2246608 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil diet (10-17 g of n-3 FAs per day)
Number of subjects: 10
Study 2246608 — intervention group
Group type: COMPARATOR
Intervention: Control diet (cocoa butter and peanut oil)
Number of subjects: 10
Study 6286274 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 258
Study 6286274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 30975738 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct aspiration (ADAPT)
Number of subjects: 300
Study 30975738 — intervention group
Group type: COMPARATOR
Intervention: Stent retriever
Number of subjects: 300
Study 27879460 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucantime therapy for 1 week after defervescence
Number of subjects: 392
Study 27879460 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucantime therapy for 7 days after defervescence
Number of subjects: 392
Study 27879460 — intervention group
Group type: COMPARATOR
Intervention: WHO's regimen (28 days)
Number of subjects: 392
Study 26472263 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective head cooling (SHC)
Number of subjects: 40
Study 26472263 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body cooling (WBC)
Number of subjects: 40
Study 23672977 — intervention group
Group type: EXPERIMENTAL
Intervention: Single priming dose of NeisVac-C® vaccine at 4 or 6 months of age
Number of subjects: 0
Study 23672977 — intervention group
Group type: COMPARATOR
Intervention: Two dose priming vaccination at 2 and 4 months of age
Number of subjects: 0
Study 23672977 — intervention group
Group type: EXPERIMENTAL
Intervention: Single priming dose of NeisVac-C® vaccine at 4 months
Number of subjects: 0
Study 21712645 — intervention group
Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 4065
Study 21712645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4065
Study 19389021 — intervention group
Group type: EXPERIMENTAL
Intervention: RBCs of 7 +/- 4 days' storage duration
Number of subjects: 43
Study 19389021 — intervention group
Group type: EXPERIMENTAL
Intervention: RBCs of 21 +/- 4 days' storage duration
Number of subjects: 43
Study 19389021 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 43
Study 17535284 — intervention group
Group type: EXPERIMENTAL
Intervention: Slim-line scaler tip (Perio Pro Line Instrument SI-11)
Number of subjects: 20
Study 17535284 — intervention group
Group type: COMPARATOR
Intervention: Conventional scaler tip (Instrument No. 3)
Number of subjects: 20
Study 16418103 — intervention group
Group type: EXPERIMENTAL
Intervention: New functional-sexological treatment
Number of subjects: 0
Study 16418103 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment (squeeze and stop-and-start techniques)
Number of subjects: 0
Study 16418103 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 0
Study 15374846 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled triamcinolone acetonide, 600 mcg, twice daily
Number of subjects: 412
Study 15374846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study 10714845 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (induction with 3 mg x kg(‐1), maintenance with 100-250 microg x kg(‐1) min(‐1))
Number of subjects: 50
Study 10714845 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (induction 7 vol.%, maintenance 2-3 vol.%)
Number of subjects: 50
Study 8942332 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% Human Albumin (HA)
Number of subjects: 56
Study 8942332 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Low-molecular weight Hydroxyethylstarch (HES)
Number of subjects: 56
Study 8942332 — intervention group
Group type: COMPARATOR
Intervention: Vasopressors (vasopressin, endothelin-1, noradrenaline, adrenaline)
Number of subjects: 56
Study 8942332 — intervention group
Group type: COMPARATOR
Intervention: Mean arterial pressure (MAP), heart rate (HR), pulmonary capillary wedge pressure (PCWP)
Number of subjects: 56
Study 1410230 — intervention group
Group type: EXPERIMENTAL
Intervention: skills-building group
Number of subjects: 91
Study 1410230 — intervention group
Group type: COMPARATOR
Intervention: information-only group
Number of subjects: 91
Study 4016930 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine, 10 mg a day for up to 120 days
Number of subjects: 29
Study 4016930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31551029 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin (RAPA)
Number of subjects: 70
Study 31551029 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin (RAPA) + all-trans retinoic acid (ATRA)
Number of subjects: 70
Study 31551029 — intervention group
Group type: COMPARATOR
Intervention: Control group (RAPA vs RAPA + ATRA)
Number of subjects: 70
Study 28679946 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary weight loss intervention
Number of subjects: 52
Study 28679946 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 52
Study 26061132 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic thyroidectomy via oral vestibular approach (ETOVA)
Number of subjects: 82
Study 26061132 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic thyroidectomy via areola approach (ETAA)
Number of subjects: 82
Study 23137700 — intervention group
Group type: EXPERIMENTAL
Intervention: bilateral continuous theta burst stimulation to the temporal cortex
Number of subjects: 48
Study 23137700 — intervention group
Group type: EXPERIMENTAL
Intervention: bilateral continuous theta burst stimulation to the temporoparietal cortex
Number of subjects: 48
Study 23137700 — intervention group
Group type: COMPARATOR
Intervention: non-cortical control site
Number of subjects: 48
Study 21704944 — intervention group
Group type: EXPERIMENTAL
Intervention: Burr-hole irrigation with drainage (BI+D)
Number of subjects: 40
Study 21704944 — intervention group
Group type: COMPARATOR
Intervention: Burr-hole irrigation without drainage (BI-D)
Number of subjects: 40
Study 19487235 — intervention group
Group type: COMPARATOR
Intervention: Bridging from oral anticoagulation (OAC) to intravenous heparin infusion (n = 51)
Number of subjects: 101
Study 19487235 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance of oral anticoagulation (OAC) to reach an INR = 2 +/- 0.3 (n = 50)
Number of subjects: 101
Study 17590310 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation period present with observation
Number of subjects: 80
Study 17590310 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation period absent with observation
Number of subjects: 80
Study 17590310 — intervention group
Group type: COMPARATOR
Intervention: Adaptation period absent without observation
Number of subjects: 80
Study 15172900 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux, 7.5 mg (5.0 mg in patients weighing <50 kg and 10.0 mg in patients weighing >100 kg) subcutaneously once daily
Number of subjects: 2205
Study 15172900 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin, 1 mg/kg of body weight, subcutaneously twice daily
Number of subjects: 2205
Study 15172900 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 2205
Study 15172900 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 2205
Study 11250761 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride cream (0.25%)
Number of subjects: 8
Study 11250761 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 8
Study 9054247 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar sympathetic nerve block with 10 ml bupivacaine (0.5%)
Number of subjects: 16
Study 9054247 — intervention group
Group type: COMPARATOR
Intervention: Contralateral placebo block with 10 ml saline
Number of subjects: 16
Study 7931867 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced methadone maintenance group
Number of subjects: 0
Study 7931867 — intervention group
Group type: COMPARATOR
Intervention: Standard methadone maintenance group
Number of subjects: 0
Study 3322956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula husk
Number of subjects: 80
Study 3322956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 3322956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula husk and Placebo
Number of subjects: 80
Study 29601570 — intervention group
Group type: EXPERIMENTAL
Intervention: MCH-ART intervention
Number of subjects: 471
Study 29601570 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 471
Study 28780543 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 138
Study 28780543 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (SEA)
Number of subjects: 138
Study 28780543 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative pain control (Control group)
Number of subjects: 138
Study 26917025 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw proximal femoral nail (PFN)
Number of subjects: 77
Study 26917025 — intervention group
Group type: EXPERIMENTAL
Intervention: Helical proximal femoral nail (PFN)
Number of subjects: 77
Study 22415358 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-Meter Walk Test
Number of subjects: 43
Study 22415358 — intervention group
Group type: COMPARATOR
Intervention: 10-Meter Walk Test
Number of subjects: 43
Study 22415358 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopwatch timing method
Number of subjects: 43
Study 22415358 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic timer timing method
Number of subjects: 43
Study 22031660 — intervention group
Group type: EXPERIMENTAL
Intervention: High-beef diet with low-saturated fat (8% E)
Number of subjects: 40
Study 22031660 — intervention group
Group type: EXPERIMENTAL
Intervention: High-beef diet with high-saturated fat (15% E)
Number of subjects: 40
Study 18835965 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.15 mg x kg(‐1) i.v.
Number of subjects: 130
Study 18835965 — intervention group
Group type: COMPARATOR
Intervention: Saline (Placebo)
Number of subjects: 130
Study 16534653 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarterial chemotherapy (IARC) after potentially curative gastrectomy
Number of subjects: 40
Study 16534653 — intervention group
Group type: COMPARATOR
Intervention: Gastrectomy only (control group)
Number of subjects: 40
Study 15562178 — intervention group
Group type: EXPERIMENTAL
Intervention: Multijoint dynamic resistance training (MJDR group)
Number of subjects: 48
Study 15562178 — intervention group
Group type: EXPERIMENTAL
Intervention: Dumbbell exercises (isolated group)
Number of subjects: 48
Study 15562178 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening programme (isokinetic group)
Number of subjects: 48
Study 15562178 — intervention group
Group type: COMPARATOR
Intervention: No strength training (control group)
Number of subjects: 48
Study 10686463 — intervention group
Group type: EXPERIMENTAL
Intervention: ferrous sulfate 325 mg b.i.d.
Number of subjects: 28
Study 10686463 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study 9189056 — intervention group
Group type: EXPERIMENTAL
Intervention: Local steroid injection (15 mg of triamcinolone hexacetonide and 1 ml of 2% lidocaine)
Number of subjects: 9
Study 9189056 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic examination
Number of subjects: 9
Study 1552198 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-J5 plasma
Number of subjects: 73
Study 1552198 — intervention group
Group type: COMPARATOR
Intervention: control plasma
Number of subjects: 73
Study 3862158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive social skills training
Number of subjects: 28
Study 3862158 — intervention group
Group type: COMPARATOR
Intervention: Holistic health therapy
Number of subjects: 28
Study 30015736 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 21
Study 30015736 — intervention group
Group type: COMPARATOR
Intervention: Cold blade
Number of subjects: 21
Study 26546248 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Reactive Protein (CRP) levels >2 mg/L
Number of subjects: 16
Study 24112375 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet+IDet (Insulin detemir with dietary intervention)
Number of subjects: 100
Study 24112375 — intervention group
Group type: COMPARATOR
Intervention: IDet (Insulin detemir alone)
Number of subjects: 100
Study 24112375 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 24188082 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy (MST)
Number of subjects: 124
Study 24188082 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 124
Study 20602168 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 142
Study 20602168 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate
Number of subjects: 142
Study 20602168 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 142
Study 17575560 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication Skills Training (CST)
Number of subjects: 30
Study 17575560 — intervention group
Group type: COMPARATOR
Intervention: Control (no CST)
Number of subjects: 30
Study 17243612 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and verapamil retard
Number of subjects: 43
Study 14671204 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg dexamethasone twice daily for 6 days
Number of subjects: 0
Study 14671204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11192708 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml of castor oil the night before imaging (Group B)
Number of subjects: 150
Study 11192708 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisacodyl the night before imaging (Group C)
Number of subjects: 150
Study 11192708 — intervention group
Group type: COMPARATOR
Intervention: No bowel preparation (Group A)
Number of subjects: 150
Study 9017787 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen bronchoprovocation
Number of subjects: 0
Study 9017787 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs effective as maintenance therapy (e.g., inhaled corticosteroids)
Number of subjects: 0
Study 9017787 — intervention group
Group type: EXPERIMENTAL
Intervention: Ineffective drugs (e.g., calcium channel blockers, ketotifen, antihistamines)
Number of subjects: 0
Study 8435990 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.5 g kg‐1 by intravenous bolus followed by 0.25 g kg‐1 h‐1
Number of subjects: 9
Study 8435990 — intervention group
Group type: COMPARATOR
Intervention: Matched volumes of saline
Number of subjects: 9
Study 8435990 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 9
Study 8435990 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 9
Study 3462013 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladosporium herbarum inhalation (concentrations: 1:100000, 1:10000, 1:1000, 1:100)
Number of subjects: 5
Study 3462013 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine inhalation (concentrations: 0.3, 0.6, 1.2, 2.4 mg/ml)
Number of subjects: 5
Study 3462013 — intervention group
Group type: COMPARATOR
Intervention: Saline inhalation
Number of subjects: 5
Study 3462013 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladosporium herbarum inhalation
Number of subjects: 5
Study 29764270 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of ethanol (blood alcohol level=80 mg%)
Number of subjects: 53
Study 29764270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 26952945 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosaprepitant 150 mg intravenously in combination with palonosetron 0.25 mg intravenously and dexamethasone 16 mg orally.
Number of subjects: 234
Study 26952945 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) in combination with palonosetron 0.25 mg intravenously and dexamethasone 16 mg orally.
Number of subjects: 234
Study 24353113 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day group (bile sampled five times per day for 2 days)
Number of subjects: 100
Study 24353113 — intervention group
Group type: COMPARATOR
Intervention: 10-day group (bile sampled once per day for 10 days)
Number of subjects: 100
Study 24353113 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day group
Number of subjects: 100
Study 24353113 — intervention group
Group type: COMPARATOR
Intervention: 10-day group
Number of subjects: 100
Study 23866410 — intervention group
Group type: COMPARATOR
Intervention: On-demand tadalafil (10mg)
Number of subjects: 100
Study 23866410 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily tadalafil (10mg)
Number of subjects: 100
Study 20831016 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiaprofenic acid
Number of subjects: 240
Study 20831016 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 240
Study 20831016 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 240
Study 18088349 — intervention group
Group type: EXPERIMENTAL
Intervention: TTP889 (300 mg once daily)
Number of subjects: 261
Study 18088349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study 15988284 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warming during surgery with countercurrent fluid warming and forced-air skin warming
Number of subjects: 76
Study 15988284 — intervention group
Group type: COMPARATOR
Intervention: Standard sterile drapes (control group)
Number of subjects: 76
Study 12490512 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine evaluation of deep calf veins
Number of subjects: 496
Study 12490512 — intervention group
Group type: COMPARATOR
Intervention: Selective evaluation of calf veins (only if symptoms or signs present)
Number of subjects: 496
Study 12449522 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg)
Number of subjects: 60
Study 12449522 — intervention group
Group type: COMPARATOR
Intervention: Granisetron plus droperidol (3 mg granisetron and 1.25 mg droperidol)
Number of subjects: 60
Study 9887116 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavored water plus 6% carbohydrate and 18 mmol/l Na (CNa)
Number of subjects: 12